Double-blind randomized trial of aflibercept versus placebo with docetaxel and prednisone for treatment of metastatic castration-resistant prostate cancer (mCRPC)

Skoneczna, Iwona Anna

Tannock, Ian

Fizazi, Karim

Ivanov, Sergey

Thellenberg-Karlsson, Camilla

Flechon, Aude

Orlandi, Francisco Jorquera

Gravis, Gwenaelle

Matveev, Vsevolod

Bavbek, Sevil E.

Gil, Thierry

Viana, Luciano S.

Aren, Osvaldo

Karyakin, Oleg

Elliott, Tony

Birtle, Alison J.

Magherini, Emmanuelle

Petrylak, Daniel Peter

Tombal, Bertrand

Rosenthal, Mark